Key result
Among patients with drug-refractory electrical storm supported by venoarterial extracorporeal membrane oxygenation, 42% survived at 6 months post-ICU admission.
Why the study?
In treatment-refractory electrical storm, hemodynamic instability prevents emergency catheter ablation, raising the potential role of venoarterial extracorporeal membrane oxygenation to restore hemodynamics and tissue perfusion until ablation can be performed safely.
Design
Retrospective, multicenter study across two centers
Follow-up
6 months post-ICU admission
Authors
Loading...
May guide VA-ECMO selection in refractory electrical storm; leaves open confirmation in randomized trials.
Cohort (n=83)
Yes
Venoarterial extracorporeal membrane oxygenation can serve as a viable rescue strategy for drug-refractory electrical storm, yielding a 42% 6-month survival rate, particularly in younger patients and those with intermittent sinus rhythm.
Baudry et al. (2020) conducted a cohort in Treatment-refractory electrical storm (n=83). Venoarterial extracorporeal membrane oxygenation was evaluated on 6-month survival. Among patients with drug-refractory electrical storm supported by venoarterial extracorporeal membrane oxygenation, 42% survived at 6 months post-ICU admission.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: